Jennifer Fulk

Jennifer Fulk joined Kura in 2026 with more than 20 years of financial and operating leadership experience spanning biopharmaceuticals, public companies and high-growth businesses. Most recently, she served as Chief Financial Officer at Soleno Therapeutics.

Ms. Fulk spent more than 15 years at Eli Lilly and Company, where she served in a series of senior finance and operating leadership roles, including Chief Financial Officer of Lilly’s U.S. Bio-Medicines business; Vice President, Investor Relations; and Executive Director, Lilly Global Oncology Finance. She has also served as Chief Financial Officer of publicly traded Talkspace, and Chief Operating Officer and Chief Financial Officer of 120Water.

Ms. Fulk holds a Bachelor of Science in Information Systems and a Master of Business Administration from Indiana University.